Nuvation Bio Inc -cw27 (NUVB-WS) Held by Superinvestors
NUVATION BIO INC -CW27 (NUVB-WS) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $6,000 based on the latest available SEC Form 13F filings for the quarter ended December 31, 2023.
Greenlight Capital is currently the largest disclosed institutional shareholder of NUVB-WS tracked by InsiderSet, reporting ownership valued at approximately $6,000 in its December 31, 2023 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $510, representing an estimated loss of -91.50% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed NUVB-WS value among the investors covered in this analysis. Major shareholders include Greenlight Capital, and several other long-term asset managers with concentrated positions in NUVATION BIO INC -CW27 (NUVB-WS).
This page ranks the largest institutional NUVB-WS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Greenlight Capital | David Einhorn | 0.00% | 100,000 | $6,000 | $510 | -$5,490 | -91.50% |
Frequently asked questions about NUVB-WS
Who are the largest superinvestors holding NUVB-WS?
The largest superinvestors holding NUVB-WS in the latest SEC Form 13F filings include Greenlight Capital. InsiderSet ranks these superinvestors by their latest reported NUVB-WS position.
What does the NUVB-WS superinvestors page include?
This page tracks NUVB-WS positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. NUVATION BIO INC -CW27 (NUVB-WS) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold NUVB-WS?
InsiderSet currently tracks 1 superinvestors reporting NUVB-WS holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own NUVB-WS.
How much NUVB-WS stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $6,000 in NUVB-WS holdings for Q4 2023. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were NUVB-WS superinvestor holdings last updated?
The latest NUVB-WS superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended December 31, 2023. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor NUVB-WS holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its NUVB-WS position after the reporting date.
Are superinvestors buying or selling NUVB-WS?
Buying and selling can be analyzed by comparing NUVB-WS positions across consecutive 13F reporting periods. InsiderSet's NUVB-WS Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View NUVB-WS ownership changes.
How have superinvestor NUVB-WS holdings changed over time?
InsiderSet tracks NUVB-WS holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.